PET/Computed Tomography: Laryngeal and Hypopharyngeal Cancers

Area of Science:

• Oncology
• Nuclear Medicine
• Radiology

Background:

• Laryngeal and hypopharyngeal tumors require multimodal treatment (surgery, radiation, chemotherapy) focused on survival and function.
• ¹⁸F FDG-PET/CT is the standard for staging and treatment response assessment in these cancers.
• Accurate TNM staging relies on understanding anatomy, tumor spread patterns, and normal ¹⁸F FDG uptake in head and neck structures.

Purpose of the Study:

• To highlight the essential role of ¹⁸F FDG-PET/CT in managing laryngeal and hypopharyngeal cancers.
• To emphasize the superiority of ¹⁸F FDG-PET/CT in detecting tumor recurrence.

Main Methods:

• ¹⁸F FDG-PET/CT imaging is utilized for staging and treatment response assessment.
• Anatomical knowledge and understanding of physiologic uptake are critical for interpretation.
• Comparison of ¹⁸F FDG-PET/CT with anatomic imaging for recurrence detection.

Main Results:

• ¹⁸F FDG-PET/CT is integral to the standard of care for laryngeal and hypopharyngeal cancers.
• Accurate staging requires detailed knowledge of head and neck anatomy and tumor spread.
• ¹⁸F FDG-PET/CT demonstrates superior sensitivity in identifying posttreatment tumor recurrence (local, regional, distant) compared to anatomic imaging.

Conclusions:

• ¹⁸F FDG-PET/CT is a vital tool for accurate staging and monitoring treatment effectiveness in laryngeal and hypopharyngeal cancer patients.
• The imaging modality significantly outperforms traditional methods in detecting recurrent disease after therapy.